These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 38474211)

  • 21. Role of polyphenols and polyphenol-rich foods in the modulation of PON1 activity and expression.
    Martini D; Del Bo' C; Porrini M; Ciappellano S; Riso P
    J Nutr Biochem; 2017 Oct; 48():1-8. PubMed ID: 28623808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacogenetics of paraoxonase activity: elucidating the role of high-density lipoprotein in disease.
    Kim DS; Marsillach J; Furlong CE; Jarvik GP
    Pharmacogenomics; 2013 Sep; 14(12):1495-515. PubMed ID: 24024900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paraoxonase 1 and homocysteine metabolism.
    Perła-Kaján J; Jakubowski H
    Amino Acids; 2012 Oct; 43(4):1405-17. PubMed ID: 22643843
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Review: The role of paraoxonase in cardiovascular diseases.
    Kowalska K; Socha E; Milnerowicz H
    Ann Clin Lab Sci; 2015; 45(2):226-33. PubMed ID: 25887882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paraoxonase 1 in neurological disorders.
    Menini T; Gugliucci A
    Redox Rep; 2014 Mar; 19(2):49-58. PubMed ID: 24225313
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreased paraoxonase-1 activity is associated with alterations of high-density lipoprotein particles in chronic liver impairment.
    Marsillach J; Aragonès G; Mackness B; Mackness M; Rull A; Beltrán-Debón R; Pedro-Botet J; Alonso-Villaverde C; Joven J; Camps J
    Lipids Health Dis; 2010 May; 9():46. PubMed ID: 20470383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atherosclerosis and arteriosclerosis parameters in stroke patients associate with paraoxonase polymorphism and esterase activities.
    Shenhar-Tsarfaty S; Waiskopf N; Ofek K; Shopin L; Usher S; Berliner S; Shapira I; Bornstein NM; Ritov Y; Soreq H; Ben Assayag E
    Eur J Neurol; 2013 Jun; 20(6):891-8. PubMed ID: 23305304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting paraoxonase-1 in atherosclerosis.
    Mackness M; Mackness B
    Expert Opin Ther Targets; 2013 Jul; 17(7):829-37. PubMed ID: 23573876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of statin therapy on paraoxonase-1 status: A systematic review and meta-analysis of 25 clinical trials.
    Ferretti G; Bacchetti T; Sahebkar A
    Prog Lipid Res; 2015 Oct; 60():50-73. PubMed ID: 26416579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Racial differences in paraoxonase-1 (PON1): a factor in the health of southerners?
    Davis KA; Crow JA; Chambers HW; Meek EC; Chambers JE
    Environ Health Perspect; 2009 Aug; 117(8):1226-31. PubMed ID: 19672401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The importance of high-density lipoproteins for paraoxonase-1 secretion, stability, and activity.
    James RW; Deakin SP
    Free Radic Biol Med; 2004 Dec; 37(12):1986-94. PubMed ID: 15544917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatic paraoxonase 1 ameliorates dysfunctional high-density lipoprotein and atherosclerosis in scavenger receptor class B type I deficient mice.
    Zhao XJ; Liu LC; Guo C; Shen WW; Cao J; Du F; Wu DF; Yu H
    Ann Transl Med; 2021 Jul; 9(13):1063. PubMed ID: 34422975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paraoxonase 1 (PON1) and stroke; the dilemma of genetic variation.
    Tajbakhsh A; Rezaee M; Rivandi M; Forouzanfar F; Afzaljavan F; Pasdar A
    Clin Biochem; 2017 Dec; 50(18):1298-1305. PubMed ID: 28779954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glycation of paraoxonase 1 by high glucose instigates endoplasmic reticulum stress to induce endothelial dysfunction in vivo.
    Yu W; Liu X; Feng L; Yang H; Yu W; Feng T; Wang S; Wang J; Liu N
    Sci Rep; 2017 Apr; 7():45827. PubMed ID: 28374834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paraoxonase 1 interactions with HDL, antioxidants and macrophages regulate atherogenesis - a protective role for HDL phospholipids.
    Efrat M; Aviram M
    Adv Exp Med Biol; 2010; 660():153-66. PubMed ID: 20221878
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-inflammatory properties of paraoxonase-1 in atherosclerosis.
    Mackness B; Mackness M
    Adv Exp Med Biol; 2010; 660():143-51. PubMed ID: 20221877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A prospective study to assess the role of paraoxonase 1 genotype and phenotype on the lipid-lowering and antioxidant activity of statins.
    Godbole C; Thaker S; Salagre S; Shivane V; Gogtay N; Thatte U
    Indian J Pharmacol; 2023; 55(3):179-184. PubMed ID: 37555413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Effects of Anthocyanins and Their Microbial Metabolites on the Expression and Enzyme Activities of Paraoxonase 1, an Important Marker of HDL Function.
    Aboufarrag HT; Needs PW; Rimbach G; Kroon PA
    Nutrients; 2019 Nov; 11(12):. PubMed ID: 31771252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Di-oleoyl phosphatidylcholine (PC-18:1) stimulates paraoxonase 1 (PON1) enzymatic and biological activities: in vitro and in vivo studies.
    Efrat M; Rosenblat M; Mahmood S; Vaya J; Aviram M
    Atherosclerosis; 2009 Feb; 202(2):461-9. PubMed ID: 18585720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How HDL protects LDL against atherogenic modification: paraoxonase 1 and other dramatis personae.
    Soran H; Schofield JD; Liu Y; Durrington PN
    Curr Opin Lipidol; 2015 Aug; 26(4):247-56. PubMed ID: 26103614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.